Patients and methods Setting This randomized controlled clinical trial study was conducted on 30 patients who presented to the Pediatric Clinical Nutrition and Neurology Units, Children`s Hospital, Faculty of Medicine, Ain Shams University (Cairo, Egypt), during the period from January 2023 to November 2023
0 g Includes 0 g Added Sugars
Recent investigations into the gut microbiome reveal a concerning prevalence of dysbiosis in ME/CFS patients, characterized by reduced microbial diversity and an imbalance between beneficial and harmful bacteria [1, 10,11,12,13,14]
Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET
These alterations of metabolism appear to benefit cancer cells, aiding in tumor proliferation and survival, through not yet fully understood mechanisms and interactions [2]